Literature DB >> 6163824

Characterization of a human B cell-specific antigen (B2) distinct from B1.

L M Nadler, P Stashenko, R Hardy, A van Agthoven, C Terhorst, S F Schlossman.   

Abstract

A human B lymphocyte-specific antigen (B2) was identified and characterized by the use of a monoclonal antibody. By indirect immunofluorescence and quantitative absorption, B2 was shown to be expressed exclusively on Ig+ B cells isolated from peripheral blood and lymphoid tissues. In contrast, B2 was not found on monocytes, resting and activated T cells, Null cells, or granulocytes, nor was it found on cell lines or tumor cells of T cell or myeloid origin. Functional studies demonstrated that only B2 antigen-positive splenocytes could be induced to differentiate into plasma cells under the stimulus of pokeweed mitogen, further confirming the B cell specificity of B2. It was then demonstrated that the B2 antigen was distinct from the previously described B cell-surface determinants including surface immunoglobulin, Ia-like antigens, and Fc and C3 receptors. More importantly, the B2 antigen has been clearly shown to be distinct from the previously described B cell-specific antigen, B1, by its m.w. and expression on normal and malignant B lymphocytes. The distinct distribution of B2 on normal and malignant lymphocytes supports the notion of B cell heterogeneity and provides further evidence for existence of subpopulations of human B lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6163824

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  81 in total

1.  Tissue distribution of the C3d/EBV-receptor: CD21 monoclonal antibodies reactive with a variety of epithelial cells, medullary thymocytes, and peripheral T-cells.

Authors:  W Timens; A Boes; H Vos; S Poppema
Journal:  Histochemistry       Date:  1991

2.  Decreased expression of complement receptor type 2 (CR2) on neoplastic B cells of chronic lymphocytic leukaemia.

Authors:  J A Tooze; D H Bevan
Journal:  Clin Exp Immunol       Date:  1991-03       Impact factor: 4.330

3.  Clinical significance of co-expression of CD21 and LFA-1 in B-cell lymphoma.

Authors:  Kazushi Tanimoto; Yoshihiro Yakushijin; Hiroshi Fujiwara; Masaki Otsuka; Koichi Ohshima; Atsuro Sugita; Akira Sakai; Takaaki Hato; Hitoshi Hasegawa; Masaki Yasukawa
Journal:  Int J Hematol       Date:  2009-04-11       Impact factor: 2.490

4.  Identification and characterization of the Epstein-Barr virus receptor on human B lymphocytes and its relationship to the C3d complement receptor (CR2).

Authors:  G R Nemerow; R Wolfert; M E McNaughton; N R Cooper
Journal:  J Virol       Date:  1985-08       Impact factor: 5.103

5.  Tonsillar mapping of determinants found on normal lymphoreticular (T,B,K, immature and macrophage) and myeloblastic leukemia cells.

Authors:  E M McMillan; L Stoneking; G B Humphrey; J Rapacz
Journal:  Am J Pathol       Date:  1987-03       Impact factor: 4.307

6.  Bone marrow aspirate and biopsy: a pathologist's perspective. II. interpretation of the bone marrow aspirate and biopsy.

Authors:  Roger S Riley; David Williams; Micaela Ross; Shawn Zhao; Alden Chesney; Bradly D Clark; Jonathan M Ben-Ezra
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

7.  Lymphocyte compartments in human spleen. An immunohistologic study in normal spleens and uninvolved spleens in Hodgkin's disease.

Authors:  W Timens; S Poppema
Journal:  Am J Pathol       Date:  1985-09       Impact factor: 4.307

8.  Autoantibody to the C3b/C4b receptor and absence of this receptor from erythrocytes of a patient with systemic lupus erythematosus.

Authors:  J G Wilson; R M Jack; W W Wong; P H Schur; D T Fearon
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

9.  Isolation of complement-fragment-iC3b-binding proteins by affinity chromatography. The identification of p150,95 as an iC3b-binding protein.

Authors:  K J Micklem; R B Sim
Journal:  Biochem J       Date:  1985-10-01       Impact factor: 3.857

10.  Immunohistologic characterization of two malignant lymphomas of germinal center type (centroblastic/centrocytic and centrocytic) with monoclonal antibodies. Follicular and diffuse lymphomas of small-cleaved-cell type are related but distinct entities.

Authors:  N L Harris; L M Nadler; A K Bhan
Journal:  Am J Pathol       Date:  1984-11       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.